Probiotix Health plc (PBX) ORD GBP0.05

ProBiotix Health plc is a United Kingdom-based life sciences company. The Company is engaged in the development of probiotics to tackle cardiovascular disease and other lifestyle conditions. Its principal product, Lactobacillus plantarum ECGC13110402 (LP-LDL), can reduce key cardiovascular risk biomarkers, such as total cholesterol, LDL (bad) cholesterol and blood pressure, by 36.7 per cent, 13.9 per cent and 5.1 per cent respectively. The Company's CholBiome products contains LP-LDL. Its products are commercialized in 60 countries. The CholBiome portfolio comprised four products, which can either be sold under the CholBiome brand or customers’ private labels: CholBiome, CholBiomeX3, CholBiomeBP and CholBiomeVH. CholBiome contains LPLDL to focus on healthy cholesterol maintenance and deliver tangible health benefits. CholBiomeX3 consists of LPLDL, Monacolin K from red yeast rice, and Vitamin B3 (niacin) to reduce cholesterol and aid overall cardiovascular health.